255 related articles for article (PubMed ID: 17010782)
1. Antiretroviral therapy: a primer for dermatologists.
Kim HN; Harrington RD
Dermatol Clin; 2006 Oct; 24(4):537-47, vii. PubMed ID: 17010782
[TBL] [Abstract][Full Text] [Related]
2. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
;
Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
[No Abstract] [Full Text] [Related]
3. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
[TBL] [Abstract][Full Text] [Related]
4. Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan.
Chang SY; Chen MY; Lee CN; Sun HY; Ko W; Chang SF; Chang KL; Hsieh SM; Sheng WH; Liu WC; Wu CH; Kao CL; Hung CC; Chang SC
J Antimicrob Chemother; 2008 Mar; 61(3):689-93. PubMed ID: 18227088
[TBL] [Abstract][Full Text] [Related]
5. HIV/AIDS pathogenesis and treatment options focusing on the viral entry inhibitors.
Jones R; Gazzard B
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):303-12. PubMed ID: 16597210
[TBL] [Abstract][Full Text] [Related]
6. What's next? Treatment options when the first antiretroviral regimen fails virologically or is not tolerated, Part 2.
Ruane PJ; Daar ES
AIDS Read; 2004 Sep; 14(9):487-98. PubMed ID: 15457602
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
[TBL] [Abstract][Full Text] [Related]
8. Selection of drug-resistant HIV-1 during the early phase of viral decay is uncommon in treatment-naïve patients initiated on a three- or four-drug antiretroviral regimen including lamivudine.
Bergroth T; Ekici H; Gisslén M; Loes SK; Goh LE; Freedman A; Lampe F; Johnson MA; Sönnerborg A
J Med Virol; 2009 Jan; 81(1):1-8. PubMed ID: 19031460
[TBL] [Abstract][Full Text] [Related]
9. Impact of HIV testing on uptake of HIV therapy among antiretroviral naive HIV-infected injection drug users.
Wood E; Kerr T; Hogg RS; Palepu A; Zhang R; Strathdee SA; Montaner JS
Drug Alcohol Rev; 2006 Sep; 25(5):451-4. PubMed ID: 16939941
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents: the recommendations of the Thai AIDS Society (TAS) 2008.
Sungkanuparph S; Anekthananon T; Hiransuthikul N; Bowonwatanuwong C; Supparatpinyo K; Mootsikapun P; Chetchotisakd P; Kiertiburanakul S; Tansuphaswadikul S; Buppanharun W; Manosuthi W; Techasathit W; Ratanasuwan W; Tantisiriwat W; Suwanagool S; Leechawengwongs M; Ruxrungtham K;
J Med Assoc Thai; 2008 Dec; 91(12):1925-35. PubMed ID: 19133532
[TBL] [Abstract][Full Text] [Related]
11. Rapid selection of drug-resistant HIV-1 during the first months of suppressive ART in treatment-naive patients.
Metzner KJ; Allers K; Rauch P; Harrer T
AIDS; 2007 Mar; 21(6):703-11. PubMed ID: 17413691
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular complications and atherosclerotic manifestations in the HIV-infected population: type, incidence and associated risk factors.
Boccara F
AIDS; 2008 Sep; 22 Suppl 3():S19-26. PubMed ID: 18845918
[TBL] [Abstract][Full Text] [Related]
13. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
[TBL] [Abstract][Full Text] [Related]
14. [The introduction of antiretroviral therapy in Malawi].
Zijlstra EE; van Oosterhout JJ
Ned Tijdschr Geneeskd; 2006 Dec; 150(50):2774-8. PubMed ID: 17225792
[TBL] [Abstract][Full Text] [Related]
15. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection.
Krogstad PA
J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216
[No Abstract] [Full Text] [Related]
16. [Antiretroviral treatment for HIV infection. Where we are and where we are going?].
Sierra-Madero JG; Franco-San-Sebastián D
Rev Invest Clin; 2004; 56(2):222-31. PubMed ID: 15377075
[TBL] [Abstract][Full Text] [Related]
17. Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.
Cozzi-Lepri A; Phillips AN; Ruiz L; Clotet B; Loveday C; Kjaer J; Mens H; Clumeck N; Viksna L; Antunes F; Machala L; Lundgren JD;
AIDS; 2007 Mar; 21(6):721-32. PubMed ID: 17413693
[TBL] [Abstract][Full Text] [Related]
18. Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'.
Hastings IM; Lalloo DG; Khoo SH
AIDS; 2007 Jan; 21(2):258-9; author reply 259-60. PubMed ID: 17197825
[No Abstract] [Full Text] [Related]
19. Antiretroviral drug resistance among antiretroviral-naïve persons with recent HIV infection in Thailand.
Apisarnthanarak A; Jirayasethpong T; Sa-nguansilp C; Thongprapai H; Kittihanukul C; Kamudamas A; Tungsathapornpong A; Mundy LM
HIV Med; 2008 May; 9(5):322-5. PubMed ID: 18400079
[TBL] [Abstract][Full Text] [Related]
20. Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.
Orrell C; Harling G; Lawn SD; Kaplan R; McNally M; Bekker LG; Wood R
Antivir Ther; 2007; 12(1):83-8. PubMed ID: 17503751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
